Marrero-Gonzalez Alejandro R, Chernov Evan S, Nguyen Shaun A, Keith Brian A, Stevens Madelyn N, Kejner Alexandra E
Medical University of South Carolina, Department of Otolaryngology - Head and Neck Surgery, Charleston, SC 29425, USA; University of Puerto Rico School of Medicine, San Juan, PR 00921, USA.
Medical University of South Carolina, Department of Otolaryngology - Head and Neck Surgery, Charleston, SC 29425, USA; SUNY Upstate Medical University, College of Medicine, Syracuse, NY 13210, USA.
Am J Otolaryngol. 2024 Nov-Dec;45(6):104464. doi: 10.1016/j.amjoto.2024.104464. Epub 2024 Aug 3.
While the presence of human papillomavirus (HPV) is known to affect the outcomes of oropharyngeal squamous cell carcinoma (OPSCC), there is a significant gap in research regarding the potential sex-based differences. This systematic review-metanalysis (SR-MA) aims to evaluate if sex is a prognostic factor in HPV-associated OPSCC.
A systematic review and meta-analysis was performed. COCHRANE Library, CINAHL, PubMed, and Scopus were searched for English-language articles from 1966 to October 2023. Studies with multivariable analysis of overall survival (OS) based on sex were included. Adjusted hazard ratios (aHRs) with a 95 % confidence interval (CI) were presented for the reported outcome. A meta-analysis of single means, proportions, and aHRs with a 95 % CI was conducted.
This SR-MA included 24 studies (n = 101,574). The proportion of female patients was 16.6 % [15.4 %-17.8 %]. A meta-analysis of all included studies with OS showed no significant difference in survival between male and female patients. In US-based studies, no significant difference in OS is observed between male and female patients. International studies reported a better OS for female patients (aHR = 0.68, 95 % CI, 0.48-0.95).
This meta-analysis suggests that sex does not represent a significant prognostic factor for patients affected by HPV associated OPSCC. When stratified by geographic location, findings suggests that female patients from the US with HPV OPSCC have similar OS than male patients but in international studies it suggests male patients have worse OS.
虽然已知人乳头瘤病毒(HPV)的存在会影响口咽鳞状细胞癌(OPSCC)的治疗结果,但关于潜在性别差异的研究存在显著差距。本系统评价-荟萃分析(SR-MA)旨在评估性别是否为HPV相关OPSCC的预后因素。
进行了系统评价和荟萃分析。检索了Cochrane图书馆、CINAHL、PubMed和Scopus数据库,以查找1966年至2023年10月的英文文章。纳入基于性别对总生存期(OS)进行多变量分析的研究。报告的结果采用调整后的风险比(aHRs)及95%置信区间(CI)表示。对单一均值、比例和aHRs及95%CI进行荟萃分析。
本SR-MA纳入了24项研究(n = 101,574)。女性患者比例为16.6%[15.4%-17.8%]。对所有纳入的OS研究进行荟萃分析显示,男性和女性患者的生存率无显著差异。在美国进行的研究中,男性和女性患者的OS无显著差异。国际研究报告女性患者的OS更好(aHR = 0.68,95%CI,0.48-0.95)。
本荟萃分析表明,性别并非HPV相关OPSCC患者的显著预后因素。按地理位置分层时,研究结果表明,美国HPV OPSCC女性患者的OS与男性患者相似,但在国际研究中,男性患者的OS较差。